lorglumide lorglumide lorglumide (cr-1409) is a drug which inhibits gastrointestinal motility and reduces gastric secretions, acting as a cholecystokinin antagonist, with fairly high selectivity for the ccka subtype. it has been suggested as a potential treatment for a variety of gastrointestinal problems including stomach ulcers, irritable bowel syndrome, dyspepsia, constipation and pancreatitis, as well as some forms of cancer, but animal and human testing has produced inconsistent results and no clear therapeutic role has been established, although it is widely used in scientific research. lorglumideclinical dataother names4--5-(dipentylamino)-5-oxopentanoic acidatc codenoneidentifiers iupac name n2-(3,4-dichlorobenzoyl-n,n-dipentyl-α-glutamine cas number97964-56-2 ypubchem cid3960iuphar/bps891chemspider3823 nuniilad1uq73bechebichebi:88305 nchemblchembl24938 ncomptox dashboard (epa)dtxsid2046961 chemical and physical dataformulac22h32cl2n2o4molar mass459.41 g·mol−13d model (jsmol)interactive image smiles cccccn(ccccc)c(=o)c(ccc(=o)o)nc(=o)c1=cc(=c(c=c1)cl)cl inchi inchi=1s/c22h32cl2n2o4/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16/h9-10,15,19h,3-8,11-14h2,1-2h3,(h,25,29)(h,27,28) nkey:iekotscybbdijc-uhfffaoysa-n n ny (what is this?) (verify)